Immorta Bio Announces Personalized Progenitor Cell Platform for Organ Specific Regeneration
/PRNewswire/ -- Immorta Bio, Inc. announced today its Personalized Progenitor Cell (PPC) platform and filing of associated intellectual property. In addition...
Source: prnewswire.com